These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16603206)

  • 41. Volumetric response of vertebrate hepatocytes challenged by osmotic gradients: a theoretical approach.
    Espelt MV; Alleva K; Amodeo G; Krumschnabel G; Rossi RC; Schwarzbaum PJ
    Comp Biochem Physiol B Biochem Mol Biol; 2008 May; 150(1):103-11. PubMed ID: 18329306
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition by acetaminophen of neoplastic initiation elicited in rat liver by the DNA-reactive hepatocarcinogen N-acetyl-2-aminofluorene.
    Williams GM; Iatropoulos MJ; Jeffrey AM; Duan JD; Perrone CE
    Eur J Cancer Prev; 2007 Dec; 16(6):528-34. PubMed ID: 18090125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in the antioxidant defense and hepatic drug metabolizing enzyme and isoenzyme levels, 8-hydroxydeoxyguanosine formation and expressions of c-raf.1 and insulin-like growth factor II genes during the stages of development of hepatocellular carcinoma in rats.
    Mukherjee B; Das T; Ghosh S; Datta S
    Eur J Cancer Prev; 2007 Aug; 16(4):363-71. PubMed ID: 17554210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The PPARgamma agonist pioglitazone inhibits early neoplastic occurrence in the rat liver.
    Borbath I; Leclercq I; Moulin P; Sempoux C; Horsmans Y
    Eur J Cancer; 2007 Jul; 43(11):1755-63. PubMed ID: 17582756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: potential roles of early DNA damage and liver metallothionein expression.
    Chakraborty T; Chatterjee A; Rana A; Srivastawa S; Damodaran S; Chatterjee M
    Life Sci; 2007 Jul; 81(6):489-99. PubMed ID: 17651763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-tumor effects of cimetidine on hepatocellular carcinomas in diethylnitrosamine-treated rats.
    Furuta K; Sato S; Miyake T; Okamoto E; Ishine J; Ishihara S; Amano Y; Adachi K; Kinoshita Y
    Oncol Rep; 2008 Feb; 19(2):361-8. PubMed ID: 18202782
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalidation of potential protein biomarkers in toxicology using iTRAQ reagent technology.
    Glückmann M; Fella K; Waidelich D; Merkel D; Kruft V; Kramer PJ; Walter Y; Hellmann J; Karas M; Kröger M
    Proteomics; 2007 May; 7(10):1564-74. PubMed ID: 17443845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bone marrow-derived cells fuse with hepatic oval cells but are not involved in hepatic tumorigenesis in the choline-deficient ethionine-supplemented diet rat model.
    Kubota K; Soeda J; Misawa R; Mihara M; Miwa S; Ise H; Takahashi M; Miyagawa S
    Carcinogenesis; 2008 Feb; 29(2):448-54. PubMed ID: 18174248
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of the Ras oncoprotein reduces proliferation of hepatocytes in vitro and in vivo in rats.
    da Silva Morais A; Saliez A; Leclercq I; Horsmans Y; Stärkel P
    Clin Sci (Lond); 2008 Jan; 114(1):73-83. PubMed ID: 17678500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Co-carcinogenic effect of cyclohexanol on the development of preneoplastic lesions in a rat hepatocarcinogenesis model.
    Márquez-Rosado L; Trejo-Solís C; Cabrales-Romero Mdel P; Arce-Popoca E; Sierra-Santoyo A; Alemán-Lazarini L; Fatel-Fazenda S; Carrasco-Legleu CE; Villa-Treviño S
    Mol Carcinog; 2007 Jul; 46(7):524-33. PubMed ID: 17393424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of glutathione S-transferase-P-negative foci accompanying nuclear factor-erythroid 2-related factor 2 expression during early stage of rat hepatocarcinogenesis.
    Fan Y; Shimizu T; Yamada T; Nanashima N; Akita M; Asano J; Tsuchida S
    Cancer Sci; 2008 Mar; 99(3):497-501. PubMed ID: 18081878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatocarcinogenesis following pancreatic islet transplantation in streptozotocin- and autoimmune-diabetic rats.
    Calvisi DF; Evert M; Dombrowski F
    Arch Physiol Biochem; 2009 May; 115(2):97-104. PubMed ID: 19485705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The inhalation exposure of carbon tetrachloride promote rat liver carcinogenesis in a medium-term liver bioassay.
    Tsujimura K; Ichinose F; Hara T; Yamasaki K; Otsuka M; Fukushima S
    Toxicol Lett; 2008 Feb; 176(3):207-14. PubMed ID: 18221844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of insulin resistance on the progression of chronic liver diseases.
    Kaji K; Yoshiji H; Kitade M; Ikenaka Y; Noguchi R; Yoshii J; Yanase K; Namisaki T; Yamazaki M; Moriya K; Tsujimoto T; Kawaratani H; Akahane T; Uemura M; Fukui H
    Int J Mol Med; 2008 Dec; 22(6):801-8. PubMed ID: 19020779
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic conversion of dietary quercetin from its conjugate to active aglycone following the induction of hepatocarcinogenesis in fisher 344 rats.
    Oi N; Hashimoto T; Kanazawa K
    J Agric Food Chem; 2008 Jan; 56(2):577-83. PubMed ID: 18092747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model.
    Bonde P; Sui G; Dhara S; Wang J; Broor A; Kim IF; Wiley JE; Marti G; Duncan M; Jaffee E; Montgomery E; Maitra A; Harmon JW
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):763-9. PubMed ID: 17320581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of the aqueous extract of the roots of Asparagus racemosus on hepatocarcinogenesis initiated by diethylnitrosamine.
    Agrawal A; Sharma M; Rai SK; Singh B; Tiwari M; Chandra R
    Phytother Res; 2008 Sep; 22(9):1175-82. PubMed ID: 18729252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HB-EGF is a paracrine growth stimulator for early tumor prestages in inflammation-associated hepatocarcinogenesis.
    Sagmeister S; Drucker C; Losert A; Grusch M; Daryabeigi A; Parzefall W; Rohr-Udilova N; Bichler C; Smedsrød B; Kandioler D; Grünberger T; Wrba F; Schulte-Hermann R; Grasl-Kraupp B
    J Hepatol; 2008 Dec; 49(6):955-64. PubMed ID: 18929421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver.
    van Hengel J; D'Hooge P; Hooghe B; Wu X; Libbrecht L; De Vos R; Quondamatteo F; Klempt M; Brakebusch C; van Roy F
    Gastroenterology; 2008 Mar; 134(3):781-92. PubMed ID: 18325391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Model Prediction and Validation of an Order Mechanism Controlling the Spatiotemporal Phenotype of Early Hepatocellular Carcinoma.
    Hoehme S; Bertaux F; Weens W; Grasl-Kraupp B; Hengstler JG; Drasdo D
    Bull Math Biol; 2018 May; 80(5):1134-1171. PubMed ID: 29568983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.